F peptide [3454]
F peptide
| SMILES | CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(N)=O)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(CCCN=C(N)N)NC(=O)C(CS)NC(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)CNC(=O)C(N)CCC(=O)O)C(C)O)C(C)CC)C(C)O)C(C)CC)C(=O)NC(CC(N)=O)C(=O)NC(CCSC)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(=O)O)C(=O)O |
| InChIKey | ITFICYZHWXDVMU-UHFFFAOYSA-N |
| Sequence | EGSDTITLPCRIKQFINMWQE |
| HELM | PEPTIDE1{E.G.S.D.T.I.T.L.P.C.R.I.K.Q.F.I.N.M.W.Q.E}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
Database connections
|
|
No bioactivity data available.
F peptide
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|